Peprazom/Peprazom IV Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Esomeprazole (DR cap: Mg; IV: Na)

Indications/Uses

Peprazom PUD & NSAID-associated ulceration, GERD & Zollinger-Ellison syndrome. Peprazom IV GERD in patient w/ esophagitis &/or severe symptoms of reflux; healing & prevention of gastric & duodenal ulcers associated w/ NSAID therapy; prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric & duodenal ulcers in adult. GERD in patient w/ erosive reflux esophagitis &/or severe symptoms of reflux in childn & adolescent 1-18 yr.

Click to view Peprazom/Peprazom IV detailed prescribing information

Dosage/Direction for Use

Peprazom Adult & adolescent (from 12 yr) Erosive reflux esophagitis 40 mg once daily for 4 wk. Long-term management of patient w/ healed esophagitis to prevent relapse 20 mg once daily. Symptomatic treatment of GERD 20 mg once daily in patient w/o esophagitis. Subsequently 20 mg once daily when needed. Adult Treatment & prevention of H. pylori-associated ulcers Esomeprazole 20 mg w/ amoxicillin 1 g + clarithromycin 500 mg, all bid for 7 days. Healing of gastric ulcers associated w/ NSAID therapy 20 mg once daily for 4-8 wk. Prevention of gastric & duodenal ulcers associated w/ NSAID therapy in patient at risk 20 mg once daily. Prevention of rebleeding of gastric & duodenal ulcers 40 mg once daily for 4 wk after IV-induced prevention of rebleeding of peptic ulcers. Zollinger-Ellison syndrome Initially 40 mg bid. Max: 80-160 mg. Doses >80 mg daily should be divided & given bid. Peprazom IV Adult Reflux esophagitis 40 mg once daily. Reflux disease 20 mg once daily. Healing of gastric ulcers associated w/ NSAID therapy 20 mg once daily. Gastric & duodenal ulcers associated w/ NSAID therapy 20 mg once daily. Prevention of rebleeding of gastric & duodenal ulcers 80 mg bolus infusion over 30 min followed by continuous IV infusion of 8 mg/hr over 72 hr. Severe liver impairment in patient w/ GERD Max: 20 mg daily. Severe liver impairment in patient w/ bleeding ulcers Initial bolus dose of 80 mg, followed by continuous IV infusion 4 mg/hr for 71.5 hr. Childn 12-18 yr Erosive reflux esophagitis 40 mg once daily. GERD 20 mg once daily. 1-11 yr <20 kg Erosive reflux esophagitis 10 mg once daily. ≥20 kg 10 mg or 20 mg once daily. GERD 10 mg once daily.

Click to view Peprazom/Peprazom IV detailed prescribing information

Overdosage

View Peprazom/Peprazom IV overdosage for action to be taken in the event of an overdose.

Administration

Should be taken on an empty stomach: Take 1 hr before meals. For patients w/ swallowing difficulties, open cap & disperse contents in a glass w/ 15 mL non-carbonated water. Do not use other liqd. Stir gently & leave for a few min to thicken. Stir again & drink immediately or w/in 30 min. Do not chew/crush granules. Mixt may also be administered via a nasogastric tube.

Contraindications

Hypersensitivity to esomeprazole, substituted benzimidazoles. Concomitant use w/ nelfinavir. Childn <12 yr. Peprazom Lactation.

Click to view Peprazom/Peprazom IV detailed prescribing information

Special Precautions

May increase risk of GI infection. Co-administration w/ atazanavir. Pregnancy. Peprazom Exclude malignancy in the presence of significant unintentional wt loss, recurrent vomiting, dysphagia, hematemesis or melena; & when gastric ulcer is suspected or present. Monitor long-term treatment (particularly for >1 yr). Fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency. Contain parahydroxybenzoate. Severe renal or hepatic impairment. Peprazom IV Hypomagnesemia. Risk of hip, wrist & spine fracture. Achlorhydria. Lactation.

Click to view Peprazom/Peprazom IV detailed prescribing information

Use In Pregnancy & Lactation

Click to view Peprazom/Peprazom IV detailed prescribing information

Adverse Reactions

Headache; abdominal pain, constipation, diarrhea, flatulence, nausea/vomiting. Peprazom IV Administration site reactions.

Click to view Peprazom/Peprazom IV detailed prescribing information

Drug Interactions

Peprazom May decrease absorption of ketoconazole & itraconazole. Increase plasma conc of diazepam, citalopram, imipramine, clomipramine, phenytoin. Warfarin or other coumarine derivatives; cisapride, clarithromycin. Peprazom IV Increased absorption w/ digoxin. Decreased serum levels w/ atazanavir & nelfinavir; rifampicin & St. John's wort. Increased C_max & AUC w/ voriconazole; cilostazol. Elevated INR w/ warfarin or other coumarin derivatives.

Click to view Peprazom/Peprazom IV detailed prescribing information

Storage

View Peprazom/Peprazom IV storage conditions for details to ensure optimal shelf-life.

Description

View Peprazom/Peprazom IV description for details of the chemical structure and excipients (inactive components).

Action

View Peprazom/Peprazom IV mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antacids, Antireflux Agents & Antiulcerants

ATC Classification

A02BC05 - esomeprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

Regulatory Classification

Presentation/Packing

Form

Peprazom DR cap 20 mg

Packing/Price

14's (P508.7/box)

Form

Peprazom DR cap 40 mg

Packing/Price

14's (P701.75/box)

Form

Peprazom IV powd for inj 40 mg

Packing/Price

1's (P572.9/box)

Peprazom/Peprazom IV

esomeprazole

Manufacturer:

Natrapharm

Distributor:

Natrapharm